✦ LIBER ✦

Repaglinide plus an insulin-sensitiser: better glycaemic control

Book ID: 120866263
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 138 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200112960-00019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Better glycaemic control with insulin gl

Better glycaemic control with insulin glargine plus glimepiride

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Better postprandial glycaemic control wi

Better postprandial glycaemic control with insulin aspart

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Glycaemic control in patients with type

Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study

✍ F. Gómez-Peralta; F. Carramiñana-Barrera; F. J. Félix-Redondo; J. Fraile-Gómez; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Improved glycaemic control with insulin

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes

✍ S. G. Ashwell; S. A. Amiel; R. W. Bilous; U. Dashora; S. R. Heller; D. A. Hepbur 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Patients with type 2 diabetes inadequate

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice

✍ H. Hammer; A. Klinge 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Troglitazone, an insulin action enhancer

Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly Type 2 diabetic patients

✍ Kumar, S.; Prange, A.; Schulze, J.; Lettis, S.; Barnett, A.H. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

The management of Type 2 diabetes mellitus with currently available oral agents may be complicated in the elderly by an increased frequency of side-effects. The effects of troglitazone, an insulin action enhancer, were studied in elderly patients with Type 2 diabetes in a double-blind, parallel-grou